Effect of BooZLiv in patients with alcoholic liver disease
Phase 4
- Conditions
- Health Condition 1: K709- Alcoholic liver disease, unspecified
- Registration Number
- CTRI/2022/08/044978
- Lead Sponsor
- MMC Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Adults aged over 18 years with the evidence of alcoholic liver disease (ALD) based on a thorough history, physical examination, and laboratory tests and all of the following:
2.Chronic alcohol intake, Identified with AUDIT(Alcohol Use Disorder Inventory Test) Questionnaire
3.Active alcohol use until 4 weeks prior to presentation
4.ALT and AST elevated >1.5 times the upper limit of normal
Over 1.5 ratio of AST to ALT
Exclusion Criteria
1.Severe alcoholic hepatitis with cirrhosis
2.Severe renal impairment
3.Participants with active viral hepatitis
4.Pregnant, attempting to conceive, or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method